Mito BioPharm
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
675 US Highway 1, North Brunswick, New J...Phone Number
+55 9176862363Website
www.mitobiopharma.comRevenue
<$5 MillionIndustry
About Mito BioPharm
MitoBio Pharma LLC focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH). The company is engaged in research and development, drug discovery, and has a pipeline of potential treatments. Their intended clients include patients suffering from liver diseases, particularly those at risk of developing NASH and related complications. MitoBio Pharma also collaborates with partners and investors to advance their therapeutic technologies.Explore more
SIC Code 87,873NAICS Code 54,541Show more
Mito BioPharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Mito BioPharm
Compare insights from companies similar to Mito BioPharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mito BioPharm Tech Stack
A closer look at the technologies used by Mito BioPharm
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mito BioPharm
Sign Up For FreeTo access detailed company insights
MitoBio Pharma LLC focuses on developing therapies for non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH). The company is engaged in research and development, drug discovery, and has a pipeline of potential treatments. Their intended clients include patients suffering from liver diseases, particula... Read More
